IG20 SPLICE VARIANTS THERAPEUTICS FOR CANCER
    1.
    发明申请
    IG20 SPLICE VARIANTS THERAPEUTICS FOR CANCER 有权
    IG20 SPLICE变量癌症治疗方案

    公开(公告)号:US20090075929A1

    公开(公告)日:2009-03-19

    申请号:US12174296

    申请日:2008-07-16

    摘要: Methods and compositions inhibit the growth of cancer cells by selectively down-regulating the expression of an IG20 splice variant including MADD. Specific knock-down of MADD splice variant resulted in the apoptosis of cancer cells. Interfering RNAs including small hairpin RNAs (shRNA) to down-regulate MADD expression in vivo are disclosed. Inhibition of MADD phosphorylation by Akt results in activation of cancer cell death. Down-regulation of MADD expression results in switching to apoptotic mode due to lack of MAPK activation upon TNF-α-based induction.

    摘要翻译: 方法和组合物通过选择性下调包括MADD的IG20剪接变体的表达来抑制癌细胞的生长。 MADD剪接变体的特异性敲低导致癌细胞凋亡。 公开了干扰RNA,包括小发夹RNA(shRNA)以体内MADD表达下调。 抑制Akt的MADD磷酸化导致癌细胞死亡的激活。 MADD表达的下调导致由于在基于TNF-α的诱导下缺乏MAPK激活而切换至凋亡模式。

    IG20 splice variants therapeutics for cancer
    2.
    发明授权
    IG20 splice variants therapeutics for cancer 有权
    IG20剪接变体治疗癌症

    公开(公告)号:US07910723B2

    公开(公告)日:2011-03-22

    申请号:US12174296

    申请日:2008-07-16

    IPC分类号: C07H21/04

    摘要: Methods and compositions inhibit the growth of cancer cells by selectively down-regulating the expression of an IG20 splice variant including MADD. Specific knock-down of MADD splice variant resulted in the apoptosis of cancer cells. Interfering RNAs including small hairpin RNAs (shRNA) to down-regulate MADD expression in vivo are disclosed. Inhibition of MADD phosphorylation by Akt results in activation of cancer cell death. Down-regulation of MADD expression results in switching to apoptotic mode due to lack of MAPK activation upon TNF-α-based induction.

    摘要翻译: 方法和组合物通过选择性下调包括MADD的IG20剪接变体的表达来抑制癌细胞的生长。 MADD剪接变体的特异性敲低导致癌细胞凋亡。 公开了干扰RNA,包括小发夹RNA(shRNA)以体内MADD表达下调。 抑制Akt的MADD磷酸化导致癌细胞死亡的激活。 MADD表达的下调导致由于在基于TNF-α的诱导下缺乏MAPK激活而切换到凋亡模式。